reagent are new and the effects of things like furimazine on cell function have not been fully characterized. e) I didn't note the presence of a section describing the cyan-colored reagent spectra, as was present for the other colors (e.g sup fig 4) . Such information would be useful because the cyan spectra is really close to the luciferase.
G & H are ok. for abstract concerns, see above (F-a)
Reviewer #2 (Remarks to the Author):
This is a well described development of a novel and highly original set of Nano-Lanterns that takes advantage of energy transfer from the bright bioluminescence protein Nanoluc to various hues of fluorescent proteins to enable multi-colour imaging without external excitation. I think these will be of wide interest to the community and open new avenues for experimentation with these unique indicators.
A substantial body of work has been presented which has been carefully undertaken and is of high quality. The simultaneous five-colour imaging and calcium indicator work is particularly impressive. The only element of the imaging that I didn't find compelling was the claim that a single clathrincoated pit was identified in Figure 1e . The resolution is not good enough and the location seems to be predominantly perinuclear. The figure legend to Figure 1f should also make clear that the outputs were submitted to spectral unmixing to separate out the colours.
The single molecule imaging (Figure 1d ) simply reflects imaging of individual particles that could represent aggregate complexes containing the GeNL lantern. How convinced are the authors that this represent single molecules of GeNL rather that single aggregates? If they are single molecules, does each detected particle have the same brightness?
The manuscript is clearly written although doesn't reference all of the previous work with NanoLucwhich perhaps it should. Some discussion should be included regarding the requirements for the NanoLuc substrate and the need for it to equally access the Nano-lanterns in different cellular locations. It would be worth expanding Supplementary Table 2 to ensure that all of the Nanlanterns have the same Km for furimazine.
Reviewer #3 (Remarks to the Author):
This paper describes the development and experimental validation of five luminescent reporter constructs. The manuscript is well written and accessible, and the experimental methodology appropriate and rigorous. Nevertheless, there are some concerns regarding the utility and capabilities of these probes.
There is no doubt that these probes could be a useful addition to the imaging toolbox, however, the authors fail to demonstrate that they offer significant advantages over conventional fluorescent probes, as suggested (lines 36-39). There is no direct comparison between the new probes and conventional probes. Furthermore, the statement that long-term Ca2+ dynamics in iPS-derived cardiomyocytes is not feasible with fluorescent imaging (line 30) is not justified. Since Ca2+ imaging has been done in iPS cardiomyocytes, the authors need to demonstrate the advantage of their approach over conventional techniques before making extraordinary claims.
The claim of single molecule resolution is intriguing (line 101-104), however, based on the evidence provided in Fig 1d, Supp Fig 10 and Note 2, this may be more speculative than the authors suggest. Given that single molecule imaging could be an important application for the probe then the claim should be better supported and included in the main body of the text, not as a supplementary note.
Reviewer #1
A. Suzuki We apologize for our poor explanation. We have added the description to explain the above points in the revised manuscript as follows:
"The weak binding between GeNL and target molecules with Ni-NTA might enable sub-diffraction imaging , a similar manner to the "universal point accumulation imaging in the nanoscale topography" (uPAINT) 17 method." c) legend, figure 2D , Which color is which sensor?
Thanks for pointing this out. We have revised the description in Figure 5 legend. We thank the referee for helping to improve our manuscript. We have added the discussion about downsides to use of bioluminescent probes as follows:
"Second, the chemiluminescent substrates may affect cell behavior. Coelenterazine is reported to possess high anti-oxidant activity against reactive oxygen species 27 (ROS). Since furimazine is an analogue of coelenterazine, it might perturb cellular physiology by disruption of signal cascades involving ROS. To minimize the potential for this effect most of our experiments use <20μM furimazine, which does not affect cell viability and morphology 4 ."
e) I didn't note the presence of a section describing the cyan-colored reagent spectra, as was present for the other colors (e.g sup fig 4). Such information would be useful because the cyan spectra is really close to the luciferase.
We apologize for the oversight. The cyan variants picked in E. coli colonies were NOT subjected to microplate reader screening on the basis of emission spectrum as the emission peaks of Nluc (donor, ~460 nm) and mTQ2 (acceptor, 480 nm) were too close to separate.
The variants were directly purified and screened in vitro on the basis of brightness and BRET efficiency. The information has been added to the Methods as follow:
"Because the emission peaks of Nluc (donor, ~460 nm) and mTQ2 (acceptor, 480 nm) were too close to discern, the cyan-variants were directly purified and screened in vitro on the basis of brightness and BRET efficiency."
Reviewer #2 (Remarks to the Author):

This is a well described development of a novel and highly original set of Nano-Lanterns that takes advantage of energy transfer from the bright bioluminescence protein Nanoluc to various hues of fluorescent proteins to enable multi-colour imaging without external excitation. I think these will be of wide interest to the community and open new avenues for experimentation with these unique indicators.
A substantial body of work has been presented which has been carefully undertaken and is of high quality. The simultaneous five-colour imaging and calcium indicator work is particularly impressive.
We are very grateful for Reviewer2's comment on our work. Figure 1e . The resolution is not good enough and the location seems to be predominantly perinuclear.
A. The only element of the imaging that I didn't find compelling was the claim that a single clathrin-coated pit was identified in
We have taken clearer images of clathrin coated pits by using a higher magnification objective lens (×100) to obtain better spatial resolution as suggested by the reviewer, the image of CCP's has been replaced in Figure 3 We note the omission regarding use of spectral unmixing to separate out colors in the legend and have included a clear statement in the revision.
C. The single molecule imaging (Figure 1d) simply reflects imaging of individual particles that could represent aggregate complexes containing the GeNL lantern. How convinced are the authors that this represent single molecules of GeNL rather that single aggregates? If they are single molecules, does each detected particle have the same brightness?
We believe these are single molecules for several reasons. Firstly, calculation of photon number from single spots obtained the value 75 ± 30 photons (mean ± SD, n = 919, Fig. 2 ). This is consistent with the predicted value estimated from the kinetic parameters associated with bulk solution analysis. Secondly, the trajectories of luminescence intensity at each ROI exhibited a stepwise transition between "Bright" states with 75 ± 30 photon emission and "Dark states" with emission similar to the background. We reasoned that those two states correspond to association and dissociation between Ni-NTA and single GeNL molecules labeled with a his-tag, which might occur within the observation times.
As this matter is potentially controversial, as it is also raised by reviewer#3, to facilitate open discussion in the wider community we moved the relevant figure and note to the result section from Supplementary Information.
D. The manuscript is clearly written although doesn't reference all of the previous work with
NanoLuc -which perhaps it should.
We appreciate this suggestion. Numerous reports cite the original NanoLuc paper ( (The paper focuses on NanoLuc technology to review its versatile applications such as bioluminescence imaging and development of BRET-based biosensors e.t.c.)
E. Some discussion should be included regarding the requirements for the NanoLuc substrate and the need for it to equally access the Nano-lanterns in different cellular locations.
We thank the referee for helping to improve our manuscript. We have added to the discussion about the requirements for the substrate and its permeability into different cellular locations as follows:
"The luminescence signal decays over time by consumption of the luminescent substrate. This issue could be overcome by implementation of perfusion with a fresh luminescent substrate."
and "Third, coelenterazine and its analogues are reported to be a substrate for multidrug We thank the referee for helping to improve our discussion regarding the characterization of eNLs. Accordinglywe have measured the K m , QY, k cat of all eNLs and added this data and description to the Supplementary Figure 9 , Table 2 and the result section, respectively, as follows:
"To investigate how the luminescence intensities of CeNL and GeNL became brighter than NLuc, we compared luminescence quantum yield (LQY) and the enzymatic parameters (K m and k cat ) of the eNLs and Nluc (see Supplementary Fig. 9 and We appreciate the reviewer raising this point. Reviewer#2 gave similar comments. We hope our response to comment C of reviewer#2 addresses the concerns of reviewer#3.
